Clinical Trials Logo
  1. Home
  2. Second Trimester Abortion
  3. NCT04063904

Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Second Trimester Abortion Clinical Trial

Official title:
Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Clinical Trial Summary

This pilot study seeks to evaluate the safety, acceptability and feasibility of a shortened outpatient procedure for medical abortion at 13-18 weeks gestation. It also seeks to document the roles of health workers in providing services related to later abortion care. Participants will take a single dose of 200 mg mifepristone orally, followed 24-48 hours later with 400 mcg misoprostol sublingually prior to arriving at the study clinic. Repeat doses of 400 mcg misoprostol will be administered sublingually every three hours at the clinic until the abortion is achieved. If expulsion does not occur by a certain time prior to the clinic closing that day, D&E will be performed to complete the abortion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04063904
Study type Interventional
Source Gynuity Health Projects
Contact
Status Terminated
Phase Phase 4
Start date October 16, 2019
Completion date April 3, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03400358 - Uterocervical Angle in the Pregnancy Termination of Multiparous Women N/A
Recruiting NCT04501809 - Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections N/A
Recruiting NCT03044093 - Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion Phase 4
Enrolling by invitation NCT06078501 - MisOpRostol Effect on Second Trimester Abortion Blood Loss Phase 3
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A
Completed NCT06164067 - The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
Completed NCT02033083 - Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation N/A
Recruiting NCT06123026 - Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion Phase 4
Terminated NCT03714880 - Cervical Preparation With Mifepristone Prior to Osmotic Dilators Phase 2
Completed NCT03407521 - Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion Phase 4